chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Difficulty breathing; Extreme flu-like symptoms; Dizzy; Fever; Splitting headache; The worst body aches ever; This is a spontaneous report from a non-contactable consumer (patient). A 36-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9269) via an unspecified route, administered in Right Arm on 08Feb2021 at 07:00 PM (36-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient's medical history included asthma. The patient had known allergies of Erythromycin. The patient's concomitant medications were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3249) via an unspecified route of administration on 15Jan2021 at 08:00 PM (36-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. Facility type Vaccine was reported as other. The patient had not received an other vaccine within four weeks prior to covid-19 vaccination. The patient was not diagnosed with covid prior to vaccination. The patient was not tested for Covid post vaccination. On 10Feb2021 at 03:00 PM, the patient had experienced extreme flu-like symptoms, dizzy, difficulty breathing, worst body aches ever, fever and splitting headache. No treatment medications were received by the patient for the resulted events. The outcome of the events was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information was expected.
None 12/2/2009 OB prenatal records received, no side effects noted from vaccine
A - pain, swelling, erythema, and itchiness at injection site. P - BENADRYL given, cool compress and monitor.
fever; back/joints hurting/ her back was killing her and every joint was hurting her.; back/joints hurting/ her back was killing her and every joint was hurting her.; cough; got really sick; might have covid; This is a spontaneous report from a contactable consumer or other non hcp.     A 57-years-old female patient received bnt162b2 (COMIRNATY PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), dose 1 via an unspecified route of administration on 08Oct2021 15:30 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was Reported that, on 11Oct2021, the patient experienced fever, back/joints hurting/ her back was killing her and every joint was hurting her, cough with outcome of recovering, got really sick and might have covid  with outcome of unknown.  Follow-up (13Oct2021): This is a follow-up spontaneous report from  a contactable 57-year-old female consumer (patient) who reported information included.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Headache, Myalgia, Arthralgia, Fever & NauseaVomiting Narrative: Employee c/o H.A., Nausea, Vommitting, loss of appetite, fever, chills, muscle aches, body aches, H.A.
Patient did not have any issues, but was given an unneccessary vaccine Engerix when he already completed 2 shots of Heplisav within the last 6 months.
4 week yr old infant was accidentally given the vaccines listed below. The infant had no signs or symptoms of distress. Also evaluated at hospital.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided. On 01-DEC-2017, the patient was administered an improperly stored dose of ROTATEQ, lot # N015129 with expiration date on 11-DEC-2018 (dose was not reported). The administered dose of vaccine underwent a temperature excursion of 47.6 degrees Fahrenheit, which lasted for an unspecified time. There was no previous temperature excursion. A digital data logger was not involved in recording the excursion. No adverse effects were reported. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1712USA008157: US-009507513-1712USA008158: US-009507513-1712USA008159: US-009507513-1712USA008160: US-009507513-1712USA008161: US-009507513-1712USA002258:
Pt developed vesicular rash and redness following MMRV. Pt was then seen in our office on 2/19/07-rash had improved according to mom had not resolved.
hospital, supportive care. On room air, no steroids or remdesivir/actemra/ baricitinib.
allergy in the arm 7 days after the shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (allergy in the arm 7 days after the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (allergy in the arm 7 days after the shot). At the time of the report, VACCINATION SITE REACTION (allergy in the arm 7 days after the shot) outcome was unknown.            Reporter did not allow further contact
Within 15-minutes of vaccination, patient reported lightheadedness and dizziness. EMS managed patient's condition on-site.
Had flu once; Initial information received on 17-Nov-2020 regarding an unsolicited valid non-serious social media case received from a consumer.   This case involves a unknown demographics patient (age at the time of reporting 86) who had flu once (influenza), while he/she received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient who had flu once (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.   Relevant laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as Unknown.  There will be no information available on the batch number for this case.
A couple days after the shot I got a 4 in rash, a painful welt just under the injection site. It went away in four days.  Then, a few days later, it came back smaller and itchy. That gets better or worse at times, is never severe, and itches.  I continue to have it two weeks after the first shot.
After receiving vaccination pt felt weak and had trouble breathing.  She was rushed to the ER where she was diagnosed with pneumonia and a mass was found on her ovary.  She stayed about 2 days and was then released under Hospice care.
About  3 hours after  the vaccination, I  was home.  I started to feel extremely light headed and might pass out.  My throat felt very numb and I had a lot difficulty swallowing.  My husband looked inside my throat and said my airway looked much smaller and he was concerned.  Went to Hospital for treatment.
Approximately 45 mins after receiving the vaccine she started itching all over her body and on her head. She was not able to sit still. She had redness on her neck and arms where she was scratching.  2:20pm 120/73, HR 121, O2 sat 100% 2:25pm 125/70 HR 111, O2 sat 98%   - Given Benadryl 50mg by mouth.  2:35pm 135/77, HR 110, O2 sat 99% 2:55pm 141/83, HR 110, O2 sat 99%  - Now just face and head itching. Able to sit still.  3:15pm 110/69, HR 107, O2 sat 99%  - Only itching on head. Redness on neck subsiding. Redness on arms is gone.  3:35pm 113/76, HR 103, O2 sat 99% - Only one spot on top of head itching now. No other symptoms of reaction to vaccine. Allowed to go home with verbal instructions to go to Emergency Department if any shortness of breath, facial or throat swelling, or if itching returns. She verbalizes understanding of and stated she had an Epi pen. Verbalizes understanding if she uses that to go to Emergency Department.  Employee Health will follow up with her tomorrow.
Patient complained of face feeling hot. No shortness of breath. No reaction at injection site. Vital signs normal. Note: Patient does not like needles.
Began having severe pain on left side of rib cage and left side of lower back on Saturday, Oct. 7th in AM. Woke up on Sunday morning, Oct. 8 around 5:50 AM to find raised bumps across the left front side of my torso above navel. Later the same day raised bumps appeared on left side of back and in the small of my back. Still lots of joint pain and extremely tired. Called Dr.'s office on Tuesday morning on Oct. 10 and was seen by Dr. At approximately 12:15 PM Dr. confirmed shingles outbreak. Was immediately started on Anti-viral, Valaciclovir HCL 1 gram TID, no pain meds prescribed as per my request.
Information has been received from a consumer (mother's patient) for the Pregnancy Registry for VARIVAX (Merck), concerning her daughter an 18 year old female with "urinary tract infection" who on 30-JUN-2009 was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot number not reported). Suspect therapy included DTaP on the same day (on 30-JUN-2009, manufacturer unspecified) (dose, route and lot number not reported). The mother reported that her daughter was already pregnant with "21 weeks" of gestation (LMP: approximately 26-MAR-2009, EDD: approximately on 8-JAN-2010), when she was vaccinated with the two vaccines on the same day (on 30-JUN-2009). The patient had recently an ultrasound performed, which revealed fluid in the baby's kidneys. At the time of the report the outcome of the patient was unknown. The patient sought unspecified medical attention. Additional information has been requested.
Site: Pain at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium
Patient had a metallic taste for 5 minutes after getting the vaccine. Called later in the evening at 5:03pm to inform me that she had white bumps/blisters all over her tongue.
to be evaluated for cough, shortness of breath, subjective fevers, and chills. Patient uncertain when symptoms started, but thinks its over the past two days. She endorses nausea, vomiting (no blood) and diffuse body aches. She reports poor appetite as well.
The caller got a third dose yesterday; The caller got a third dose yesterday; Arm is a lot sorer than the first two shots; This is a spontaneous report received from Pfizer Sponsored Program. A contactable 73-year-old female consumer (patient) reported for herself that a 73-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 3 via an unspecified route of administration on 04Aug2021 12:00 (at the age of 73-year-old) (Batch/Lot Number: RC3180) as dose 3, single for covid-19 immunisation. The patient medical history included diabetes mellitus, overweight and immunodeficiency. The patient concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on end of Jan2021 (Batch/Lot Number: unknown) as dose 1, single and dose 2 via an unspecified route of administration on mid Feb2021 (Batch/Lot Number: unknown) as dose 2, single for covid-19 immunisation. 04Aug2021 12:00 the caller got her third dose of the vaccine and then went to breakfast. The patient arm was a lot sorer than the first two shots on 04Aug2021. This started 2-3 hours after the shot and it got progressively worse at night. The caller made it her business not to sleep on that arm. The clinical outcome of event arm was a lot sorer than the first two shots was not recovered.  Follow-up activities closed. Batch/lot number not available for BNT162B2.
Throat closing; Swelling of throat; Lip swollen; Shortness of breath; Tachycardia; Swelling of face; A spontaneous report was received from a healthcare professional concerning a 38-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced throat closing, swelling of the face and throat, shortness of breath, tachycardia and lip swollen.  The patient's medical history was not provided. Concomitant product use was not reported.  On 11 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number: 041L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Jan 2021, one day after vaccine administration, the patient was sent to the hospital by ambulance after her throat closed. She had swelling of face and throat, shortness of breath and tachycardia.  In the ambulance, diphenhydramine, methylprednisolone, and famotidine were administered. She was discharged four hours later with prednisone, diphenhydramine, epinephrine, famotidine, and loratadine.  On 15 Jan 2021, the patient was still having daily flare ups of a swollen lip and throat closing.  Action taken with mRNA-1273 in response to the events was not reported.  The events, throat closing and lip swollen, were considered not resolved. The outcome of the events, swelling of the face and throat, shortness of breath, and tachycardia, was unknown.; Reporter's Comments: This spontaneous report concerns a 38-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced throat closing, swelling of the face, shortness of breath, tachycardia and lip swollen. The events occurred 1 day after the administration of mRNA-1273 vaccine (Lot number: 041L20A, expiration date: unknown).  Treatment provided include diphenhydramine, methylprednisolone and famotidine and outcome is unknown for swelling of the face, shortness of breath and tachycardia. Throat closing and lip swollen are not resolved. Based on the information provided which shows a temporal association, a causal association between the reported events and the administration of mRNA-1273 vaccine cannot be excluded.
Pt came to office 3/17/21 with reaction -she had received at another facility on 3/13/21. Pt reports received through school district/employer. Received COVID vaccine LA and felt "tingling" all over and told staff who told her it was normal. Later that day her left arm developed hives, with significant edema and erythema and puritis. She was evaluated in our office on 3/17/21- no respiratory distress, or perioral edema. Advised to use antihistamine and hydrocortisone and reviewed red flags. Returned on 3/19/21 with improving symptoms.
the night of 4/30/21 started to get a slight fever of 100.5. at 2:00am on 5/1/21 i woke straight up with bodyaches, fever of 102.8, headache, nausea, vomited x 3 times, SOB,  diarrhea, chills which all lasted till sunday 5/2/21. on 5/2/21 the area of the injection started to itchy, be painful and the become red and swollen with heat, the injection site to this day on 5/4/21 the redness of the site getting bigger and itching and painful more and going up my left shoulder area.
Patient received Hep A  vaccine,  expiration date on 10/15/2022. Patient's mother notified by provider.
Patient came to pharmacy to receive annual flu shot, by mistake received first dose of Pfizer COVID-19 vaccine.  Patient is currently not in age range for approved vaccination. At time patient left, was showing no ill effects.
pt has long hx of asthma & has allergies to many things, but eggs has caused no problems in the past; is allergic to peanut butter; hives & red blothes lips & eyes swollen, peak flows down-reported by mom;
Approximately  11-12 hours  after receiving my second dose of Moderna?s COVID-19 Vaccine on 2/3/21 (received first dose on 1/6/21), I began suddenly feeling symptoms such as: fatigue, chills, body aches, headache, and fever (103 degrees Fahrenheit). The symptoms came on suddenly/abruptly. The fever lasted approximately 24 hours and the other symptoms lasted approximately 48 hours.
I developed symptoms of runny/stuffy nose, sore throat. Then I was tired and fatigued. On April 1 I had a positive COVID-19 test. I slept 20 hours a day, lose of appetite, exhaustion, and coughing. I feel it could have been worse if not vaccinated. I called my doctor and they advised me to isolate.
Patient tested positive for COVID-19 after completing the full Pfizer vaccine series, 70 days after 2nd dose.   Patient received 2nd dose of COVID vaccine on 1/8/21 .   Tested positive on 3/19/21.   NOT hospitalized. reported being in contact with someone confirmed/suspected for COVID-19.
Patient reports exacerbation of MS including extreme fatigue which began 2 days post vaccination, lasted approximately 1 week and increased visual acuity in the left eye which occurred approximately 4 days post vaccination.  Reports about 90% of visual acuity has now returned.  Patient did not receive any medical attention for these reactions.
A patient had 2 doses of VAXELIS so far and developed fever after the 1st dose and the 2nd dose; This non-serious spontaneous safety report, reference number 02329597, was received by a partner on 02-FEB-2023 and forwarded on 03-FEB-2023, from a non-health professional.   The reporter did not assess the causal relationship between Vaxelis and the reported event "A patient had 2 doses of VAXELIS so far and developed fever after the 1st dose and the 2nd dose".  No further information is expected given that the reporter did not give consent to be contacted.
On 06/29/21 at 1340 a 37 year old female patient complained of feeling weak and dizzy 1 minutes after receiving JJ vaccine. Pt's initial BP was 97/62, after 3 minutes she stated she felt better and last BP was 116/73. Pt was observed for an additional 30 minutes and then left with family.
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness / still dizzy), ASTHENIA (weakness / still weak), SKIN WARM (skin is hot), PRURITUS (itchy really bad) and PERIPHERAL SWELLING (feet are swollen really bad,  swollen leg) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 002CZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced DIZZINESS (dizziness / still dizzy), ASTHENIA (weakness / still weak), RASH (couple of days later rash spread over his arm and to body), MYALGIA (body aches / muscle aches), ARTHRALGIA (joint aches), HEADACHE (Headache) and NAUSEA (nausea / still having nausea). On an unknown date, the patient experienced SKIN WARM (skin is hot), PRURITUS (itchy really bad), PERIPHERAL SWELLING (feet are swollen really bad,  swollen leg), DYSPNOEA (short of breath), CHEST PAIN (chest pain), JOINT SWELLING (Swollen ankle), VACCINATION COMPLICATION (Not feeling well), PYREXIA (fever that lasted about a week and half) and VACCINATION SITE RASH (rash on left shoulder where they administer the vaccine). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness / still dizzy), ASTHENIA (weakness / still weak), SKIN WARM (skin is hot), PRURITUS (itchy really bad), PERIPHERAL SWELLING (feet are swollen really bad,  swollen leg), DYSPNOEA (short of breath) and NAUSEA (nausea / still having nausea) had not resolved and CHEST PAIN (chest pain), JOINT SWELLING (Swollen ankle), VACCINATION COMPLICATION (Not feeling well), RASH (couple of days later rash spread over his arm and to body), PYREXIA (fever that lasted about a week and half), MYALGIA (body aches / muscle aches), ARTHRALGIA (joint aches), HEADACHE (Headache) and VACCINATION SITE RASH (rash on left shoulder where they administer the vaccine) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was provided. Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Followup received contains  added new events chest pain. On 06-Aug-2021: Follow-up received on 06-Aug-2021 included no new information.
Redness, fever ,soreness , vomiting, extreme fatigue, shortness of breath
Patient stated that he had numbness along the right side of body. Patient had symptoms since shot was given. Stated gradually going away. Also has pain and discomfort in the right elbow and knee at times.
Fournier gangrene with associated severe sepsis. Underwent I&D on 11/30/2021 was followed by general surgery service. GS of wound culture: GPC, GNR.  No organisms seen.  No pathogens isolated. Has been on Vanco and Zosyn. Given the location of the wound,  I have prescribed Bactrim for 1 more week. Patient will discharge home with home care/wound care service. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Two weeks before Thanksgiving, mother says patient had cold symptoms, coughing and nasal congestion. The week of Thanksgiving, Nov. 24, 2008, patient c/o difficulty breathing, chest pains and a headache. To hospital emergency room. Patient was admitted and hospitalized two days in ICU and three days on the hematology unit according to mother. Diagnosis, Pulmonary Embolism.  Another emergency visit to hospital on Feb. 13, 2009 for symptoms of diarrhea and bloody stools. 2/25/09-records received for DOS 11/24-11/28/08-DC DX: Pulmonary embolism. Presented with increasing shortness of breath, worsening cough anc chest wall pain for 2 weeks. Seen in Ed 1 week prior with shortness of breath and CXR determined to be asthma.
pt devel pallor-skin cool diaphoresis, n/v w/in 15min of vax;BP 90/40;observed x 20-30min w/relief;cont to c/o pallor, cool skin temp, nausea;advised eval in ER;mom declined & observed pt @ home 4-5hr & called nurse back stated pt ok;
Missed second dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Included no new information.; Reporter's Comments: This report refers to a case of Missed Dose for mRNA-1273, lot # unknown  with no associated AEs.